Becca Press

Director, Consumer Marketing at Pfizer

Becca Press is a seasoned professional in the pharmaceutical and advertising sectors, currently serving as Consumer Senior Manager at Pfizer since March 2024. Prior to this position, Becca held the role of Client Service Lead at minds + assembly from February 2020 to March 2024, and gained extensive experience at TBWA\Chiat\Day from January 2017 to February 2020, where Becca worked as Group Account Supervisor and Account Manager. Earlier roles include Account Executive and Account Coordinator at Saatchi & Saatchi Wellness from June 2015 to January 2017. Becca Press earned a degree in Neuroscience from Franklin & Marshall College.

Location

New York, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams


Offices


Pfizer

614 followers

Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.